13 Fanconi Anemia Clinical Trials in Nashville, TN (2026)

Q: How do I join a clinical trial in Nashville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you.

Recruiting Fanconi Anemia Studies in Nashville

NCT03437486Recruiting

Mechanisms of Familial Pulmonary Fibrosis

This a prospective, longitudinal study of first-degree family members of patients diagnosed with familial interstitial pneumonia (FIP). FIP is the familial form of idiopathic pulmonary fibrosis (IPF),...

Nashville, TN750 participantsVanderbilt University Medical Center

View Study Details

NCT06877793Recruiting

Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling

Necrotizing soft-tissue infections (NSTIs, a.k.a. "necrotizing fasciitis" or "flesh-eating bacteria") are aggressive infections that can progress rapidly from mild symptoms to sepsis, multi-organ fail...

Nashville, TN420 participantsEric R. Henderson

View Study Details

NCT06939751Recruiting

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

This study aims to develop and refine a microRNA (miR) biomarker panel that can be used to phenotype net immune state after heart transplantation using circulating miRs (associated with drug doses and...

Nashville, TN250 participantsInova Health Care Services

View Study Details

NCT06532890Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict p...

Nashville, TN150 participantsInova Health Care Services

View Study Details

NCT06055439Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

The goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least ...

Nashville, TN135 participantsChimeric Therapeutics

View Study Details

NCT07462377Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

A phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with locally advanced or metastatic HNSCC and ...

Nashville, TN110 participantsEpiBiologics

View Study Details

NCT06479876Recruiting

Home-Based Cardiac Rehabilitation for Patients With Heart Failure

The vast majority of individuals with heart failure do not participate in center based cardiac rehabilitation (CBCR). While steps to increase utilization of CBCR are important, many individuals will s...

Nashville, TN100 participantsVanderbilt University Medical Center

View Study Details

NCT04941599Recruiting

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

The Investigators will test the hypothesis that 2-HOBA will reduce modification of HDL and LDL and improve HDL function in humans with heterozygous FH. The Investigators plan to first study subjects w...

Nashville, TN72 participantsVanderbilt University Medical Center

View Study Details

NCT05489575Recruiting

CPAP for the Treatment of Supine Hypertension

This study aims to learn about the effects of continuous positive airway pressure (CPAP) on people with autonomic failure and high blood pressure when lying down (supine hypertension) to determine if ...

Nashville, TN59 participantsVanderbilt University Medical Center

View Study Details

NCT06150950Recruiting

REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failur...

Nashville, TN50 participantsStanford University

View Study Details

NCT04246437Recruiting

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Alpha-synucleinopathies refer to age-related neurodegenerative and dementing disorders, characterized by the accumulation of alpha-synuclein in neurons and/or glia. The anatomical location of alpha-sy...

Nashville, TN40 participantsDaniel Claassen

View Study Details

NCT02897063Recruiting

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

The purpose of this study is to learn more about the effects of midodrine and droxidopa, two medications used for the treatment of orthostatic hypotension (low blood pressure on standing), on the vein...

Nashville, TN34 participantsVanderbilt University Medical Center

View Study Details

NCT07385651Recruiting

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

The goal of this clinical trial is to test how storage temperature of deceased donor kidneys affects kidney function after transplant in adult patients receiving a kidney transplant. The main questio...

Nashville, TN30 participantsVanderbilt University Medical Center

View Study Details

About Fanconi Anemia Clinical Trials in Nashville

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 13 fanconi anemia clinical trials recruiting participants in Nashville, TN. These studies are seeking a combined 2,200 participants. Research is being sponsored by Vanderbilt University Medical Center, Eric R. Henderson, Inova Health Care Services and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Nashville — FAQ

Are there fanconi anemia clinical trials in Nashville?

Yes, there are 13 fanconi anemia clinical trials currently recruiting in Nashville, TN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 13 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov